October 10, 2016 / 12:12 PM / in a year

BRIEF-Crescendo Biologics, Takeda enter collaboration for Humabody-based therapeutics worth up to $790 mln

Oct 10 (Reuters) - Takeda Pharmaceutical Co Ltd :

* Crescendo Biologics and Takeda enter collaboration for Humabody-based therapeutics worth up to $790m

* Crescendo Biologics - eligible to receive up to $36 million, in a combination of an upfront payment, investment, research funding, preclinical milestones

* Crescendo Biologics Limited - Takeda will have right to develop and commercialize humabody(reg)-based therapeutics resulting from collaboration

* Crescendo Biologics - will be eligible to receive royalties on humabody(reg)-based product sales by Takeda Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below